Meningococcal disease: Epidemiology and control of secondary cases;Doença meningocócica: Epidemiologia e controle dos casos secundários

Revista de Saude Publica

Volumn 32, Issue 1, 1998, Pages 89-97

  Barroso, David E ^a,c   De Carvalho, Diana M ^b   Nogueira, Susie A ^b   Solari, Claude A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NONE   (Brazil)

Author keywords

Chemoprevention; Meningitis, meningococcal, epidemiology; Neisseria meningitidis

Indexed keywords

CIPROFLOXACIN; MENINGOCOCCUS VACCINE; RIFAMPICIN;

CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; REVIEW; VACCINATION; EPIDEMIC MENINGITIS; HUMAN;

HUMANS; MENINGITIS, MENINGOCOCCAL;

EID: 0031831164     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89101998000100014     Document Type: Article

References (59)

1. ACHTMAN, M. Epidemic spread and antigenic variability of Neisseria meningitidis. Trends Microbiol., 3:186-92, 1995.
2. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP). Uses of vaccines and immune globulins in persons with altered immunocompetence. Morb. Mortal. Wkly. Rep., 42 (RR-4):1-18, 1993.
3. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP). Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Morb. Mortal. Wkly. Rep., 46 (RR-5):1-21, 1997.
4. ANDRADE, J.G. et al. Prevalência de portador de Neisseria meningitidis em uma comunidade fechada. Rev. Goiana Med., 32:67-72, 1986.
5. BARQUET, N. et al. Primary meningococcal conjunctivitis: report of 21 patients and review. Rev. Infect. Dis., 12:838-47, 1990.
6. BARROSO, D.E. Epidemiologia e controle da infecção por Neisseria meningitidis emfamilias de pacientes com doença meningocócica internados no Instituto Estadual de Infectologia São Sebastião. Rio de Janeiro, 1994. [Tese de Mestrado - Instituto Oswaldo Cruz da FIOCRUZ].
7. BARROSO, D.E. et al. Epidemiology and molecular analysis of epidemic meningococcal disease related to group C Neisseria meningitidis in a Brazilian metropolis: Rio de Janeiro, 1993-1995. In: International Pathogenic Neisseria Conference, 10., Baltimore, 1996. Proceedings. Baltimore, 1996. p. 435-7.
8. BARROSO, D.E. et al. Antimicrobial susceptibility test for evaluation of Neisseria meningitidis C isolated during an urban epidemic, Rio de Janeiro 1993-1995. In: International Pathogenic Neisseria Conference, 10., Baltimore, 1996. Proceedings. Baltimore, 1996b. p. 433-4.
9. BEESON, P.B. & WESTERMAN, E. Cerebrospinal fever: analysis of 3,575 case reports, with special reference to sulphonamide therapy. Br. Med. J., 1:497-500, 1943.
10. BEGG, N. Outbreak management. In: Cartwright, K. Meningococcal disease. West Sussex, John Wiley & Sons, 1995. p. 285-305.
11. BLAKEBROUGH, I.S. et al. The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J. Infect. Dis., 146:626-37, 1982.
12. BRAHAMS, D. Meningitis, schools, and public alarm. [Letter] Lancet, 339:1532, 1992.
13. BROOKS, J.L. et al. Sequence variation in class 1 outer membrane protein in Neisseria meningitidis isolated from patients with meningococcal infection and close household contacts. FEMS Microbiol. Lett., 128:145-50, 1995.
14. CARTER, P.E. et al. Molecular characterisation of rifampin-resistant Neisseria meningitidis. Antimicrob. Agents Chemother., 38:1256-61, 1994.
15. CARTWRIGHT, K.A.V. et al. An outbreak of meningococcal disease in Gloucestershire. Lancet, 2:558-61, 1986.
16. CARTWRIGHT, K.A.V. et al. The stonehouse survey: nasofaringeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect., 99:591-601, 1987.
17. CARTWRIGHT, K.A.V. et al. Meningococcal carriage in close contacts of cases. Epidemiol. Infect., 106:133-41, 1991.
18. COMMUNICABLE DISEASE SURVEILLANCE CENTRE (CDSC). Sporadic cases of meningococcal disease in schools. Commun. Dis. Rep., 2:209, 1992.
19. COMMUNICABLE DISEASE SURVEILLANCE CENTRE (CDSC). Control of meningococcal disease. Commun. Dis. Rep., 3:229-30, 1993.
20. COMMUNICABLE DISEASE SURVEILLANCE CENTRE (CDSC). Control of meningococcal disease: guidance for consultants in communicable disease control and for microbiologists. Commun. Dis. Rep., 5:R189-98, 1995a.
21. COMMUNICABLE DISEASE SURVEILLANCE CENTRE (CDSC). Cluster of invasive meningococcal infection in schools. Commun. Dis. Rep., 5:291, 1995b.
22. COOKE, R.P.D. et al. Secondary cases of meningococcal infections among close family and household contacts in England and Wales, 1984 - 87. BMJ., 298:555-8, 1989.
23. COOPER, E.R. et al. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin. J. Pediatr., 108:93-6, 1986.
24. CUEVAS, L.E. et al. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparinson of ciprofloxacin and rifampicin. J. Infect. Dis., 171:728-31, 1995.
25. CVEJTANOVIC', B. Strategy for control. In: Vedros, N.A. Evolution of meningococcal disease. Florida, CRC Press, 1987. p. 135-43.
26. DAVIES, A.L. et al. Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection. Epidemiol. Infect., 117:259-66, 1996.
27. EDWARDS, E.A. et al. Immunological investigation of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand. J. Infect. Dis., 9:105-10, 1977.
28. GREENWOOD, B.M. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis. Rev. Infect. Dis., 6:374-89, 1984.
29. GREENWOOD, B.M. Bacterial meningitis. In: Strickland, G.T. Hunter's tropical medicine. Philadelphia, WB Saunders, 1991. p. 385-99.
30. HARRISON, L.H. et al. A cluster of meningococcal disease on a school bus following epidemic influenza. Arch. Intern. Med., 151:1005-9, 1991.
31. HART, C.A. & ROGERS, T.R.F. Meningococcal disease. J. Med. Microbiol., 39:3-25, 1993.
32. HOUCK, P. et al. Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response. Public Health Rep., 110:343-9, 1995.
33. HUDSON, P.J. et al. Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr. Infect. Dis., 5:213-7, 1986.
34. IMREY, P.B. etal. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am. J. Epidemiol., 143:624-30, 1996.
35. JACKSON, E.A. et al. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA, 273:383-9, 1995.
36. JAFFE, D.M. Occult bacteremia in children. Adv. Pediat. Infect. Dis., 9:237-60, 1994.
37. JONES, D.M. Chemoprophylaxis of meningitis. Trans. R. Soc. Trop. Med. Hyg., 85:44-5, 1991.
38. MENINGOCOCCAL DISEASE SURVEILLANCE GROUP (MDSG). Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. J. Am. Med. Assoc., 235:261-5, 1976a.
39. MENINGOCOCCAL DISEASE SURVEILLANCE GROUP (MDSG). Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J. Infect. Dis., 134:201-4, 1976b.
40. MINISTÉRIO DA SAÚDE. Guia de vigilância epidemiológica. Brasilia, CENEPI/FNS, 1994.
41. MITCHELL, L.A. et al. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents. J. Infect. Dis., 173:1009-13, 1996.
42. MOORE, P.S. & BROOME, C.V. Cerebrospinal meningitis epidemics. Sci. Am., 27:24-31, 1994.
43. MORAGA, F.A. et al. Invasive meningococcal conjunctivitis. [Letter] J. Am. Med. Assoc., 264:333-4, 1990.
44. MORROW, H.W. et al. Risk factors associated with a school-related outbreak of serogroup C meningococcal disease. Pediatr. Infect. Dis. J., 9:394-8, 1990.
45. MUNFORD, R.S. et al. Spread of meningococcal infection within households. Lancet, 1:1275-8, 1974.
46. NORTON, J.F. & BAISLEY, I.E. Meningococcus meningitis in Detroit in 1928-1929. J. Prev. Med., 5:357-67, 1931.
47. OLCÉN, P. et al. Epidemiology of Neisseria meningitidis: prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand. J. Infect. Dis., 13:105-9, 1981.
48. PELTOLA, H. et al. Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet, 2:595-7, 1982.
49. PELTOLA, H. Meningococcal disease still with us. Rev. Infect. Dis., 5:71-91, 1983.
50. RIZZI, D.A. & PEDERSEN, S.A. Causality in medicine: towards a theory and terminology. Theor. Med., 13:233-54, 1992.
51. RONNE, T. et al. Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. Scand. J. Infect. Dis., 25:331-9, 1993.
52. SPRATT, E.G. et al. Population genetics of the Neisseria and its relevance to molecular epidemiology and typing methods. In: International Pathogenic Neisseria Conference, 10., Baltimore, 1996. Proceedings, Baltimore, 1996. p. 409-14.
53. STANSFIELD, R.E. et al. Primary meningococcal conjunctivitis and the need for prophylaxis in close contacts. J. Infect., 29:211-4, 1994.
54. WALL, R.A. et al. Meningococcal bacteremia in febrile contacts of patients with meningococcal disease. [Letter] Lancet, 2 624, 1986.
55. WALL, R.A. The chemoprophylaxis of meningococcal infection. J. Antimicrob. Chemother., 21:698-700, 1988.
56. WALL, R. et al. Meningococcal infection: evidence for school transmission. J. Infect., 23:155-9, 1991.
57. WEIS, N. & LIND, I. Pharyngeal carriage of Neisseria meningitidis before and after the treatment of meningococcal disease. J. Med. Microbiol., 41:339-42, 1994.
58. WHO WORKING GROUP. Control of epidemic meningococcal disease: WHO practical guidelines. Lyon, Fondation Marcel Mérieux, 1995.
59. YAGUPSKY, P. et al. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis. Lancet, 341: 1152-3, 1993.